Walker, Daniel J.

Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: Results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial ☆

Russell, J. I., Mease, P. J., Smith, T. R., Kajdasz, D. K., Wohlreich, M. M., Detke, M. J., Walker, D. J., Chappell, A. S., & Arnold, L. M. (2008) · Pain

Fibromyalgia and Chronic Fatigue Syndrome ResearchPain Mechanisms and Treatments

Cited by 367

The Potential for Misuse and Abuse of Medications in ADHD: A Review

Clemow, D. B., & Walker, D. J. (2014) · Postgraduate Medicine

Attention Deficit Hyperactivity DisorderNeuroethics, Human Enhancement, Biomedical Innovations

Cited by 198

Estimation of minimum clinically important difference for pain in fibromyalgia

Mease, P. J., Spaeth, M., Clauw, D. J., Arnold, L. M., Bradley, L. A., Russell, I. J., Kajdasz, D. K., Walker, D. J., & Chappell, A. S. (2011) · Arthritis Care & Research

Fibromyalgia and Chronic Fatigue Syndrome ResearchMusculoskeletal pain and rehabilitation

Cited by 171

Long-Term Safety, Tolerability, and Efficacy of Duloxetine in the Treatment of Fibromyalgia

Mease, P. J., Russell, I. J., Kajdasz, D. K., Wiltse, C. G., Detke, M. J., Wohlreich, M. M., Walker, D. J., & Chappell, A. S. (2010) · Seminars in Arthritis and Rheumatism

Fibromyalgia and Chronic Fatigue Syndrome ResearchPain Mechanisms and Treatments

Cited by 54

Safety and tolerability of duloxetine in the treatment of patients with fibromyalgia: pooled analysis of data from five clinical trials

Choy, E. H. S., Mease, P. J., Kajdasz, D. K., Wohlreich, M. M., Crits-Christoph, P., Walker, D. J., & Chappell, A. S. (2009) · Clinical Rheumatology

Fibromyalgia and Chronic Fatigue Syndrome ResearchPharmacovigilance and Adverse Drug Reactions

Cited by 47

Duloxetine in the Prevention of Depressive Recurrences: A Randomized, Double-Blind, Placebo-Controlled Trial

Perahia, D. G. S., Maina, G., Thase, M. E., Spann, M. E., Wang, F., Walker, D. J., & Detke, M. J. (2009) · The Journal of Clinical Psychiatry

Treatment of Major DepressionBipolar Disorder and Treatment

Cited by 47

Single- and Multiple-Dose Pharmacokinetic, Safety, and Tolerability Profiles of Olanzapine Long-Acting Injection: An Open-Label, Multicenter, Nonrandomized Study in Patients With Schizophrenia

Mitchell, M., Kothare, P., Bergstrom, R., Zhao, F., Jen, K. Y., Walker, D., Johnson, J., & McDonnell, D. (2013) · Clinical Therapeutics

Schizophrenia research and treatmentTreatment of Major Depression

Cited by 31